BIOMAT Database Logo BIOMAT Database Logo

L-asparaginase effect on antithrombin-III levels. 1979

N Anderson, and J J Lokich, and J L Tullis

The effect of L-asparaginase (L-asp) therapy on circulating antithrombin-III (AT-III) was monitored in three patients with acute lymphoblastic leukemia. Serial determination for AT-III by both a functional assay and an immunologic assay demonstrated a rapid decrease in serum AT-III levels, followed by a protracted recovery beyond the period of L-asp exposure. One of the three patients developed a reversible venous thrombosis of the arm. The mechanism of the L-asparaginase effect may be related to peripheral degradation of AT-III or to inhibition of production.

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I
D001215 Asparaginase A hydrolase enzyme that converts L-asparagine and water to L-aspartate and NH3. EC 3.5.1.1. Asparaginase II,Asparaginase medac,Asparagine Deaminase,Colaspase,Crasnitin,Elspar,Erwinase,Kidrolase,Leunase,Paronal,Deaminase, Asparagine,medac, Asparaginase
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides

Related Publications

N Anderson, and J J Lokich, and J L Tullis
Reduced antithrombin III levels during L-asparaginase therapy.
January 1980, Medical and pediatric oncology,
N Anderson, and J J Lokich, and J L Tullis
L-asparaginase, antithrombin III, and thrombosis.
May 1980, Lancet (London, England),
N Anderson, and J J Lokich, and J L Tullis
Antithrombin III concentrations associated with L-asparaginase administration.
January 1992, Veterinary clinical pathology,
N Anderson, and J J Lokich, and J L Tullis
[L-asparaginase, antithrombin III deficiency and thromboses (author's transl)].
November 1981, Archives francaises de pediatrie,
N Anderson, and J J Lokich, and J L Tullis
Hypercoagulability during L-asparaginase treatment: the effect of antithrombin III supplementation in vivo.
April 1990, British journal of haematology,
N Anderson, and J J Lokich, and J L Tullis
Antithrombin III deficiency during asparaginase therapy.
March 1980, Lancet (London, England),
N Anderson, and J J Lokich, and J L Tullis
Antithrombin III deficiency during asparaginase therapy.
March 1980, Lancet (London, England),
N Anderson, and J J Lokich, and J L Tullis
Antithrombin supplementation III in childhood acute lymphoblastic leukemia treated with L-asparaginase.
December 2002, Pediatric hematology and oncology,
N Anderson, and J J Lokich, and J L Tullis
[Monitoring therapy with L-asparaginase. Model of drug-induced antithrombin III deficiency].
November 1985, Fortschritte der Medizin,
N Anderson, and J J Lokich, and J L Tullis
Effect of anticoagulant therapy on antithrombin III levels.
August 1982, Journal of the American Medical Women's Association (1972),
Copied contents to your clipboard!